Skip to main content
Equibles

Dale Curtis Hogue, Jr.

CEO

Alaunos Therapeutics, Inc. (TCRT)

Board Member

Alaunos Therapeutics, Inc. (TCRT)

Equibles does not estimate personal net worth.

Get an email with a short summary when Alaunos Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get TCRT alerts

About Dale Curtis Hogue, Jr.

Dale Curtis Hogue, Jr. is recorded as CEO at Alaunos Therapeutics, Inc. (TCRT) since January 20, 2024 and Board Member at Alaunos Therapeutics, Inc. (TCRT) since December 29, 2023. Alaunos Therapeutics, Inc. reported in an 8-K filed July 2, 2025 that Dale Curtis Hogue, Jr. resigned as Director, effective July 1, 2025. Alaunos Therapeutics, Inc. reported in an 8-K filed July 2, 2025 that Dale Curtis Hogue, Jr. resigned as Chief Executive Officer, effective July 1, 2025. Alaunos Therapeutics, Inc. reported in an 8-K filed January 22, 2024 that Dale Curtis Hogue, Jr. was appointed Interim Chief Executive Officer, effective January 20, 2024. Equibles holds 4 filed executive changes naming Dale Curtis Hogue, Jr.; each is listed under recent activity with its source filing. Alaunos Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alaunos Therapeutics, Inc. includes Heidi Hagen (CEO and Board Member), Holger Weis (CEO, Chairman and Board Member), Kevin Boyle (CEO and Board Member) and 7 others.

“On July 1, 2025, Dale Curtis Hogue, Jr. notified the Company of his resignation from the board of directors (the "Board") of Alaunos Therapeutics, Inc. (the "Company") and his position as Chief Executive Officer, effective immediately.”
Alaunos Therapeutics, Inc. Form 8-K, filed July 2, 2025 · Read the filing
“On July 1, 2025, Dale Curtis Hogue, Jr. notified the Company of his resignation from the board of directors (the "Board") of Alaunos Therapeutics, Inc. (the "Company") and his position as Chief Executive Officer, effective immediately.”
Alaunos Therapeutics, Inc. Form 8-K, filed July 2, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Alaunos Therapeutics, Inc.

Recent activity